Brendan Teehan, EVP, COO, Head of Commercial: Acadia Pharmaceuticals ACAD Sell · Filed 24/11/19

Trade details

Type: Insider sale
Amount: $173,630.49
Shares · price: 10,329 sh · $16.81 a share
Held after: 62,105 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Brendan TeehanEVP, COO, Head of Commercial
Trade date: 24/11/19
Filed: 24/11/19
Days to filing: 0 days

Sold 14.3% of holdings

Share of holding sold: 14.3%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/10/20~24/12/19

Brendan Teehan's recent trades

Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$145.7K
9,534 sh
$145.7K
Filed 24/08/20
Traded 24/08/19
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$58.9K
3,477 sh
$58.9K
Filed 24/05/03
Traded 24/05/02
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$45.9K
2,568 sh
$45.9K
Filed 24/04/09
Traded 24/04/08
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$92K
5,140 sh
$92K
Filed 24/03/27
Traded 24/03/27
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$15.4K
624 sh
$15.4K
Filed 24/02/27
Traded 24/02/26